Target intelligence / Profile preview

Potassium channel subfamily K member 3 (KCNK3) (TASK-1)

Target
TASK-1
Molecular classification
Ion channel, Two-pore domain potassium channel (K2P), Potassium channel
01

Overview

Potassium channel subfamily K member 3 (KCNK3), commonly known as TASK-1, is a member of the two-pore domain potassium (K2P) channel family that mediates background leak currents essential for setting the resting membrane potential (UniProt: P48524). It is primarily expressed in the heart, lungs, and central nervous system, where it regulates cellular excitability and responds to physiological stimuli such as extracellular pH and oxygen levels (PubMed: 10903571). In the cardiovascular system, TASK-1 is a key determinant of atrial repolarization and pulmonary vascular tone, making it a significant factor in the pathogenesis of atrial fibrillation and pulmonary arterial hypertension (PubMed: 31554101, 23644490). Pharmacological inhibition of TASK-1 is being explored as a strategy to treat rhythm disorders by prolonging the atrial refractory period, while its activation is investigated for reducing pulmonary resistance. Drugs such as doxapram and various experimental small molecules (e.g., BAY 2586116) interact with the channel's pore or sensing domains to modulate its activity (IUPHAR/BPS Guide to Pharmacology). Understanding TASK-1's role in chemoreception also highlights its potential as a target for respiratory conditions like sleep apnea (PubMed: 32810011).

Other names
K2P3.1TBAK-1Acid-sensitive potassium channel protein 1Two pore domain potassium channel TASK-1TWIK-related acid-sensitive K+ channel 1
02

Mechanism of action

TASK-1 modulators typically function as pore blockers (inhibitors) to increase cellular excitability and prolong action potential duration, or as activators to hyperpolarize the membrane and reduce excitability (IUPHAR/BPS Guide to Pharmacology).

03

Biological functions

Maintenance of resting membrane potential (UniProt: P48524)Regulation of cellular excitabilitypH sensing (PubMed: 10903571)Potassium homeostasisChemoreception in carotid bodies (PubMed: 10903571)
04

Disease associations

Atrial fibrillation (PubMed: 31554101)Pulmonary arterial hypertension (PubMed: 23644490)Sleep apnea (PubMed: 32810011)Primary aldosteronism (PubMed: 24013636)Cancer (PubMed: 28630117)
05

Safety considerations

Pro-arrhythmic risk due to prolongation of the QT intervalImpaired ventilatory response to hypoxia or hypercapniaPotential for systemic hypertension due to effects on vascular toneOff-target effects on adrenal steroidogenesis
06

Interacting drugs

Doxapram

8 more in the full profile.

07

Biomarkers

KCNK3 genetic mutations (PubMed: 23644490)TASK-1 protein expression levels in atrial tissueKCNK3 mRNA expression in pulmonary artery smooth muscle cells

Beyond the preview

Go deeper on Potassium channel subfamily K member 3 (KCNK3) (TASK-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel subfamily K member 3 (KCNK3) (TASK-1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call